Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
08/2012
08/23/2012US20120213819 Hemagglutinin polypeptides, and reagents and methods relating thereto
08/16/2012WO2012109280A2 Apoe immunotherapy
08/16/2012US20120207820 Composition for treatment of multiple sclerosis
08/16/2012CA2825791A1 Apoe immunotherapy
08/15/2012CN101787387B Acid-resistant no-bitterness soybean oligopeptide and production method and application thereof
08/15/2012CN101039953B Therapeutic and diagnostic agents
08/14/2012USRE43581 Peptide epitopes of apolipoprotein B
08/14/2012US8241856 Using filaggrin concentration in bodily fluids to diagnose arthritic disorders; immunoassay
08/09/2012US20120204275 Apoe immunotherapy
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
07/2012
07/25/2012CN102605030A Enzymatic extraction method for oat peptide
07/24/2012US8226976 Method of using cell-free protein synthesis to produce a membrane protein
07/19/2012WO2012030217A3 Culture medium for eukaryotic cells
07/19/2012US20120183964 Mammalian cytokine; related reagents
07/19/2012US20120183599 Pharmaceutical Composition
07/19/2012US20120183578 Polyethylene glycol-based dendrons
07/19/2012US20120183478 Compositions, Devices, and Methods related to Prostate-Specific Membrane Antigen
07/18/2012CN102586376A Albumen antioxidant peptide and preparation method thereof
07/18/2012CN102584936A Processing method of producing Yunzi glycopeptide by adopting membrane method
07/12/2012US20120177568 Novel meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof
07/10/2012US8217140 Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
07/05/2012US20120172309 Transglutaminase-activating peptide and cosmetic or pharmaceutial composition containing same
07/04/2012CN101607913B 改进的螯合剂缀合物 Improved chelator conjugate
07/03/2012US8212002 Synthesis of glatiramer acetate
06/2012
06/28/2012US20120164659 Human hcv-interacting proteins and methods of use
06/27/2012CN101704877B Method for preparing soybean peptide
06/26/2012US8207302 Maize cellulose synthases and uses thereof
06/26/2012US8206719 KDR peptides and vaccines comprising the same
06/14/2012US20120148674 Self-assembling hydrogels based on dicephalic peptide amphiphiles
06/07/2012US20120142585 Leptin antagonist and methods of use
06/07/2012US20120142584 Novel transporter constructs and transporter cargo conjugate molecules
06/07/2012US20120141527 Structured viral peptide compositions and methods of use
06/05/2012US8193312 Bone morphogenic protein binding peptide
05/2012
05/31/2012US20120134991 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function
05/29/2012US8188219 Cyclic peptide for use in diagnosis, prevention and treatment of bone disorders
05/29/2012CA2441597C Elongated and multiple spacers in activatible prodrugs
05/22/2012CA2348956C Immunotherapeutic methods using epitopes of wt-1 and gata-1
05/17/2012US20120121537 Methods and Compositions for Inhibiting Hepatitis C Virus Replication
05/16/2012EP2002259B1 Disheveled PDZ modulators
05/10/2012US20120115796 Novel Spacer Moiety for Poly(ehtylene Glycol) Modified Peptide Based Compounds
05/10/2012US20120114557 Methods for Collagen Imaging
05/08/2012US8173768 Peptides having antimicrobial and neurotrophic activity and uses thereof
05/03/2012WO2012055162A1 Momordica charantia polypeptide, preparation method therefor and use thereof
04/2012
04/26/2012US20120101044 Gold (iii) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents
04/25/2012EP2444410A2 Brachyury polypeptides and methods for use
04/25/2012CN102428094A Collagen peptide composition having good blood transfer properties, and food and drink containing same
04/24/2012US8163701 Prodrugs of active agents
04/24/2012CA2614171C Copolymers for suppression of autoimmune diseases, and methods of use
04/19/2012US20120094920 Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolyzate that can reinforce the barrier function
04/19/2012US20120093873 Molecular Interactions in Hematopoietic Cells
04/19/2012US20120093844 Antimicrobial peptides based on cmap27
04/17/2012US8158857 Monocot seed product comprising a human serum albumin protein
04/10/2012US8153758 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
04/05/2012US20120083442 Myostatin binding agents
04/05/2012US20120083427 Kinase and phosphatase assays
03/2012
03/29/2012WO2012040062A1 Mosquitocidal xenorhabdus, lipopeptide and methods
03/29/2012WO2011157610A3 Use of novel amino acid derivatives as agents for treating human perspiration, and compositions containing them
03/29/2012US20120076815 Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/29/2012CA2811797A1 Mosquitocidal xenorhabdus, lipopeptide and methods
03/27/2012US8143373 Carbohydrate-containing pan cancer marker
03/22/2012US20120071400 Lipid metabolism-improving reagent
03/22/2012US20120071396 Compositions and Methods for Inhibiting the Interaction Between CFTR and CAL
03/21/2012EP1387854B1 Sfrp and peptide motifs that interact with sfrp and methods of their use
03/20/2012US8138304 Neural regeneration peptides and formulations thereof
03/15/2012WO2011157609A3 Use of amino acid derivatives as agents for treating human perspiration, peptide derivatives, and compositions containing them
03/15/2012US20120065368 Cyclodextrin-based polymers for therapeutics delivery
03/08/2012WO2012030217A2 Culture medium for eukaryotic cells
03/08/2012US20120059147 Method for site-selectively cleaving target nucleic acid
03/08/2012US20120058953 Compositions and methods for enhancing apoptosis
03/08/2012US20120058908 Universal Tags, Probes and Detection Methods For Multiple Targets Detection of Biomolecules
03/08/2012US20120058202 Means and Method for Ovarian Cancer Prognosis
03/08/2012US20120058146 Immunogens from uropathogenic escherichia coli
03/08/2012CA2807895A1 Culture medium for eukaryotic cells
03/01/2012US20120054906 Method for Preparation and Purification of Recombinant Proteins
03/01/2012US20120053123 Natriuretic polypeptides having mutations within their disulfide rings
03/01/2012US20120052569 Tag peptide having a protease recognition sequence and use thereof
02/2012
02/23/2012WO2012023641A1 Peptide for controlling red algal blooms having an anti-algal activity against red-bloom-inducing organisms, a use therefor and a production method therefor
02/23/2012US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
02/21/2012US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally
02/21/2012US8119139 Immunotherapy against several tumors including neuronal and brain tumors
02/16/2012US20120041171 Process for the production of a recombinant polypeptide of interest
02/15/2012CN1609617B 诊断与预防严重急性呼吸道综合症（sars）的组合物和方法 Diagnosis and compositions and methods for the prevention of severe acute respiratory syndrome (sars) of
02/14/2012US8114431 Biomolecular coating for implants
02/09/2012US20120035320 Polyacridine nucleic acid delivery peptide complexes
02/09/2012US20120035095 Orally administered peptides synergize statin activity
02/09/2012US20120034594 Methylocystis Strain SB2 Materials and Methods
02/07/2012US8110654 T cell epitope peptides of ovarian cancer anti-idiotypic antibody 6B11 and use thereof
02/02/2012WO2011036443A9 S1 protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders
02/02/2012US20120028880 Vegfr-1/nrp-1 targeting peptides
02/02/2012US20120027677 Prion-specific peptoid reagents
01/2012
01/31/2012US8106158 Compositions and methods for fusion protein separation
01/26/2012US20120021530 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS
01/25/2012CN102329842A Lamb placenta polypeptide and preparation method thereof
01/25/2012CN102329841A Lamb placenta protein and preparation method thereof
01/19/2012US20120015887 Synthetic peptide and uses thereof
01/19/2012US20120014873 Peptides whose uptake by cells is controllable
01/12/2012WO2003085121A9 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
01/12/2012US20120010557 Drug Delivery System for Use in the Treatment of Vascular and Vessel-Related Pathologies
01/05/2012WO2011125040A3 New polyterpene type compounds, compositions containing them and topical uses thereof
01/03/2012US8088887 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 22